Differential Expression of COL1A1, COL1A2, COL6A3, and SULF1 as Prognostic Biomarkers in Gastric Cancer

Yan Hu, Jingjing Li, Haifeng Luo, Wenli Song, Jiyuan Yang Department of Oncology, The First People’s Hospital of Jingzhou, Jingzhou, Hubei, 434000, People’s Republic of ChinaCorrespondence: Yan HuDepartment of Oncology, The First People’s Hospital of Jingzhou, Jingzhou, Hubei, 434000, People’s Repub...

Full description

Bibliographic Details
Main Authors: Hu Y, Li J, Luo H, Song W, Yang J
Format: Article
Language:English
Published: Dove Medical Press 2021-09-01
Series:International Journal of General Medicine
Subjects:
Online Access:https://www.dovepress.com/differential-expression-of-col1a1-col1a2-col6a3-and-sulf1-as-prognosti-peer-reviewed-fulltext-article-IJGM
id doaj-eb5e8554a6ce4e598b15eb83d6f13907
record_format Article
spelling doaj-eb5e8554a6ce4e598b15eb83d6f139072021-09-16T19:51:46ZengDove Medical PressInternational Journal of General Medicine1178-70742021-09-01Volume 145835584368920Differential Expression of COL1A1, COL1A2, COL6A3, and SULF1 as Prognostic Biomarkers in Gastric CancerHu YLi JLuo HSong WYang JYan Hu, Jingjing Li, Haifeng Luo, Wenli Song, Jiyuan Yang Department of Oncology, The First People’s Hospital of Jingzhou, Jingzhou, Hubei, 434000, People’s Republic of ChinaCorrespondence: Yan HuDepartment of Oncology, The First People’s Hospital of Jingzhou, Jingzhou, Hubei, 434000, People’s Republic of ChinaTel +86 716 8513623Email yanhu_dr@outlook.comBackground: Gastric cancer (GC) is among the most prevalent cancers globally. As such, there is a need to explore the mechanism underlying its pathogenesis and identify potential biomarkers for its prognosis.Methods: ONCOMINE was used to screen differentially expressed genes between GC and normal gastric mucosa. GEPIA was used to analyze the expression and correlation of candidate genes in tumor node metastasis (TNM) stage. STRING was used to construct protein interaction network. Kaplan–Meier plotter was used to analyze survival. TIMER was used to evaluate the association between candidate genes and immune cell infiltration.Results: From the ONCOMINE database, we found COL1A1, COL1A2, COL6A3, and SULF1 genes were significantly upregulated in stomach adenocarcinomas. There was a considerable correlation between the expression of COL1A1 (p = 0.029), COL1A2 (p = 0.004), COL6A3 (p = 0.002), SULF1 (p = 0.001), and the TNM stage. COL1A1 was positively correlated with ERBB2 (R = − 0.037, p = 0.46), while the other three genes were negatively correlated with ERBB2 (p > 0.05). The Kaplan–Meier plotter showed that low transcriptional levels of COL1A1 (p = 0.0020), COL1A2 (p = 0.0015), COL6A3 (p = 0.0015), and SULF1 (p = 0.0016) in gastric cancer patients were remarkably related to longer overall survival. In addition, there was a close relationship between chemokine expression and infiltration of the six immune cell types: B cells, macrophages, CD4+ T cells, CD8+ T cells, dendritic cells, and neutrophils, implying that the genes acted as indicators of both prognosis and immune status.Conclusion: Our findings implicate COL1A1, COL1A2, COL6A3, and SULF1 as candidate biomarkers for the prognosis of gastric cancer.Keywords: gastric cancer, biomarker, prognosishttps://www.dovepress.com/differential-expression-of-col1a1-col1a2-col6a3-and-sulf1-as-prognosti-peer-reviewed-fulltext-article-IJGMgastric cancerbiomarkerprognosis
collection DOAJ
language English
format Article
sources DOAJ
author Hu Y
Li J
Luo H
Song W
Yang J
spellingShingle Hu Y
Li J
Luo H
Song W
Yang J
Differential Expression of COL1A1, COL1A2, COL6A3, and SULF1 as Prognostic Biomarkers in Gastric Cancer
International Journal of General Medicine
gastric cancer
biomarker
prognosis
author_facet Hu Y
Li J
Luo H
Song W
Yang J
author_sort Hu Y
title Differential Expression of COL1A1, COL1A2, COL6A3, and SULF1 as Prognostic Biomarkers in Gastric Cancer
title_short Differential Expression of COL1A1, COL1A2, COL6A3, and SULF1 as Prognostic Biomarkers in Gastric Cancer
title_full Differential Expression of COL1A1, COL1A2, COL6A3, and SULF1 as Prognostic Biomarkers in Gastric Cancer
title_fullStr Differential Expression of COL1A1, COL1A2, COL6A3, and SULF1 as Prognostic Biomarkers in Gastric Cancer
title_full_unstemmed Differential Expression of COL1A1, COL1A2, COL6A3, and SULF1 as Prognostic Biomarkers in Gastric Cancer
title_sort differential expression of col1a1, col1a2, col6a3, and sulf1 as prognostic biomarkers in gastric cancer
publisher Dove Medical Press
series International Journal of General Medicine
issn 1178-7074
publishDate 2021-09-01
description Yan Hu, Jingjing Li, Haifeng Luo, Wenli Song, Jiyuan Yang Department of Oncology, The First People’s Hospital of Jingzhou, Jingzhou, Hubei, 434000, People’s Republic of ChinaCorrespondence: Yan HuDepartment of Oncology, The First People’s Hospital of Jingzhou, Jingzhou, Hubei, 434000, People’s Republic of ChinaTel +86 716 8513623Email yanhu_dr@outlook.comBackground: Gastric cancer (GC) is among the most prevalent cancers globally. As such, there is a need to explore the mechanism underlying its pathogenesis and identify potential biomarkers for its prognosis.Methods: ONCOMINE was used to screen differentially expressed genes between GC and normal gastric mucosa. GEPIA was used to analyze the expression and correlation of candidate genes in tumor node metastasis (TNM) stage. STRING was used to construct protein interaction network. Kaplan–Meier plotter was used to analyze survival. TIMER was used to evaluate the association between candidate genes and immune cell infiltration.Results: From the ONCOMINE database, we found COL1A1, COL1A2, COL6A3, and SULF1 genes were significantly upregulated in stomach adenocarcinomas. There was a considerable correlation between the expression of COL1A1 (p = 0.029), COL1A2 (p = 0.004), COL6A3 (p = 0.002), SULF1 (p = 0.001), and the TNM stage. COL1A1 was positively correlated with ERBB2 (R = − 0.037, p = 0.46), while the other three genes were negatively correlated with ERBB2 (p > 0.05). The Kaplan–Meier plotter showed that low transcriptional levels of COL1A1 (p = 0.0020), COL1A2 (p = 0.0015), COL6A3 (p = 0.0015), and SULF1 (p = 0.0016) in gastric cancer patients were remarkably related to longer overall survival. In addition, there was a close relationship between chemokine expression and infiltration of the six immune cell types: B cells, macrophages, CD4+ T cells, CD8+ T cells, dendritic cells, and neutrophils, implying that the genes acted as indicators of both prognosis and immune status.Conclusion: Our findings implicate COL1A1, COL1A2, COL6A3, and SULF1 as candidate biomarkers for the prognosis of gastric cancer.Keywords: gastric cancer, biomarker, prognosis
topic gastric cancer
biomarker
prognosis
url https://www.dovepress.com/differential-expression-of-col1a1-col1a2-col6a3-and-sulf1-as-prognosti-peer-reviewed-fulltext-article-IJGM
work_keys_str_mv AT huy differentialexpressionofcol1a1col1a2col6a3andsulf1asprognosticbiomarkersingastriccancer
AT lij differentialexpressionofcol1a1col1a2col6a3andsulf1asprognosticbiomarkersingastriccancer
AT luoh differentialexpressionofcol1a1col1a2col6a3andsulf1asprognosticbiomarkersingastriccancer
AT songw differentialexpressionofcol1a1col1a2col6a3andsulf1asprognosticbiomarkersingastriccancer
AT yangj differentialexpressionofcol1a1col1a2col6a3andsulf1asprognosticbiomarkersingastriccancer
_version_ 1717377943258267648